Washington, U.S. | Xinhua | The U.S. Food and Drug Administration (FDA) on Thursday authorized American pharmaceutical company Merck’s oral antiviral for the treatment of mild-to-moderate COVID-19, the second pill approved for treating COVID-19 following the one from Pfizer. Merck’s pill, called molnupiravir, is authorized to use in adults with positive …
Read More »African scientists race to test COVID drugs
In a bid to stave off looming disaster, scientists are trying to repurpose drugs used for malaria and other diseases, but infrastructure and recruitment challenges stymie progress | ABDULLAHI TSANNI | For more than a year, Adeola Fowotade struggled to recruit people to a clinical trial for COVID-19 treatments. A …
Read More »Molnupiravir approved to treat early COVID-19
How antiviral pill that costs Shs2.4m per doze shot ahead in the COVID drug hunt | THE INDEPENDENT | On November 4, the United Kingdom became the first country in the world to grant conditional authorisation to a drug used to treat COVID-19. The Molnupiravir antiviral pill manufactured by the …
Read More »